These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25386219)

  • 21. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
    Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
    J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the blood urea nitrogen-to-left ventricular ejection fraction ratio with contrast-induced nephropathy in patients with acute coronary syndrome who underwent percutaneous coronary intervention.
    Kiris T; Avci E; Celik A
    Int Urol Nephrol; 2019 Mar; 51(3):475-481. PubMed ID: 30604231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LC-MS-based metabolomics reveals metabolic changes in short- and long-term administration of Compound Danshen Dripping Pills against acute myocardial infarction in rats.
    Zhang L; Wang LL; Zeng H; Li B; Yang H; Wang GJ; Li P
    Phytomedicine; 2022 Sep; 104():154269. PubMed ID: 35717805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease.
    Li C; Li Q; Xu J; Wu W; Wu Y; Xie J; Yang X
    Evid Based Complement Alternat Med; 2020; 2020():5067137. PubMed ID: 33281912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention.
    Azzalini L; Poletti E; Lombardo F; Laricchia A; Beneduce A; Moscardelli S; Bellini B; Maccagni D; Cappelletti A; Ancona MB; Carlino M; Chieffo A; Colombo A; Montorfano M
    Int J Cardiol; 2019 Sep; 290():59-63. PubMed ID: 31005417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of compound danshen dripping pill combined with intravenous transplantation of human umbilical cord blood mononuclear cells on local inflammatory response in the myocardium of rabbits with acute myocardial infarction].
    Deng LX; Yu GL; Al Q; Yuan CJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1532-7. PubMed ID: 24483116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
    Wang L; Pu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease.
    Demir OM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A; Azzalini L
    Am J Cardiol; 2018 Dec; 122(11):1837-1842. PubMed ID: 30292337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of short-term cordyceps sinensis for prevention of contrast-induced nephropathy in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention.
    Zhao K; Lin Y; Li YJ; Gao S
    Int J Clin Exp Med; 2014; 7(12):5758-64. PubMed ID: 25664103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventive Effects of Alprostadil Against Contrast-Induced Nephropathy Inpatients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
    Yang SC; Fu NK; Zhang J; Liang M; Cong HL; Lin WH; Tian FS; Lu CZ; Sun TT; Zhang WY; Ma ZH
    Angiology; 2018 May; 69(5):393-399. PubMed ID: 29073785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome.
    Xu ZR; Chen J; Liu YH; Liu Y; Tan N
    BMC Cardiovasc Disord; 2019 Feb; 19(1):36. PubMed ID: 30744553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome.
    Senoo T; Motohiro M; Kamihata H; Yamamoto S; Isono T; Manabe K; Sakuma T; Yoshida S; Sutani Y; Iwasaka T
    Am J Cardiol; 2010 Mar; 105(5):624-8. PubMed ID: 20185007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive Effects of Nicorandil Against Contrast-Induced Nephropathy in Patients With Moderate Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
    Zhang P; Li WY; Yang SC; Fu NK; Liu XG; Zhang X; Cong HL; Lin WH; Tian FS; Lu CZ; Zhang J
    Angiology; 2020 Feb; 71(2):183-188. PubMed ID: 30987432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
    Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease.
    Ebisawa S; Kurita T; Tanaka N; Nasu K; Kimura M; Ito T; Kinoshita Y; Tsuchikane E; Terashima M; Suzuki T
    Cardiovasc Interv Ther; 2016 Jan; 31(1):13-20. PubMed ID: 26001976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of preprocedural high-sensitivity C-reactive protein on contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention.
    Jian-Wei Z; Yu-Jie Z; Shu-Jun C; Qing Y; Shi-Wei Y; Bin N
    Angiology; 2014 May; 65(5):402-7. PubMed ID: 23539615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of central pulse pressure with contrast-induced nephropathy and clinical outcomes in patients undergoing coronary intervention.
    Huang SS; Huang PH; Leu HB; Wu TC; Lin SJ; Chen JW
    J Hypertens; 2013 Nov; 31(11):2187-94. PubMed ID: 23868087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
    Barbieri L; Verdoia M; Marino P; Suryapranata H; De Luca G;
    Eur J Prev Cardiol; 2016 Jun; 23(9):931-7. PubMed ID: 26525064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
    Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
    Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.